Correlation Between Aldeyra and Tarsus PharmaceuticalsI

Can any of the company-specific risk be diversified away by investing in both Aldeyra and Tarsus PharmaceuticalsI at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aldeyra and Tarsus PharmaceuticalsI into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Aldeyra and Tarsus PharmaceuticalsInc, you can compare the effects of market volatilities on Aldeyra and Tarsus PharmaceuticalsI and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aldeyra with a short position of Tarsus PharmaceuticalsI. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aldeyra and Tarsus PharmaceuticalsI.

Diversification Opportunities for Aldeyra and Tarsus PharmaceuticalsI

0.57

Correlation Coefficient

Aldeyra  Tarsus PharmaceuticalsI

Very weak diversification

The 3 months correlation between Aldeyra and Tarsus is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Aldeyra and Tarsus PharmaceuticalsInc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tarsus PharmaceuticalsInc and Aldeyra is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aldeyra are associated (or correlated) with Tarsus PharmaceuticalsI. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tarsus PharmaceuticalsInc has no effect on the direction of Aldeyra i.e., Aldeyra and Tarsus PharmaceuticalsI go up and down completely randomly.

Pair Corralation between Aldeyra and Tarsus PharmaceuticalsI

Given the investment horizon of 90 days Aldeyra is expected to generate 2.1 times more return on investment than Tarsus PharmaceuticalsI. However, Aldeyra is 2.1 times more volatile than Tarsus PharmaceuticalsInc. It trades about 0.2 of its potential returns per unit of risk. Tarsus PharmaceuticalsInc is currently generating about -0.2 per unit of risk. If you would invest  327.00  in Aldeyra on January 31, 2024 and sell it today you would earn a total of  78.00  from holding Aldeyra or generate 23.85% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	95.45%
Values	Daily Returns

Aldeyra  vs.  Tarsus PharmaceuticalsInc

Aldeyra

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Aldeyra are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain fundamental indicators, Aldeyra showed solid returns over the last few months and may actually be approaching a breakup point.

Tarsus PharmaceuticalsInc

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Tarsus PharmaceuticalsInc are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Tarsus PharmaceuticalsI unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Aldeyra and Tarsus PharmaceuticalsI

The main advantage of trading using opposite Aldeyra and Tarsus PharmaceuticalsI positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aldeyra position performs unexpectedly, Tarsus PharmaceuticalsI can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tarsus PharmaceuticalsI will offset losses from the drop in Tarsus PharmaceuticalsI's long position.

The idea behind Aldeyra and Tarsus PharmaceuticalsInc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.